Financhill
Sell
42

PRK Quote, Financials, Valuation and Earnings

Last price:
$158.52
Seasonality move :
0.78%
Day range:
$158.03 - $160.43
52-week range:
$137.97 - $179.48
Dividend yield:
2.7%
P/E ratio:
14.61x
P/S ratio:
3.90x
P/B ratio:
1.91x
Volume:
68.6K
Avg. volume:
73.1K
1-year change:
-9.38%
Market cap:
$2.5B
Revenue:
$645.4M
EPS (TTM):
$10.85

Earnings Data

Next earnings date for PRK
Jan 26
2026
Most recent earnings per share
$2.92
Beat by $0.18
(Oct 27/2025)
Consensus Estimate
$2.74
(Oct 27/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

PRK Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
01/26/2026 Q4 $142.1M -- -- $2.80 --
10/27/2025 Q3 $140.1M $169.5M $2.92 $2.74 $0.18
07/28/2025 Q2 $134.9M $168.7M $2.97 $2.45 $0.52
04/28/2025 Q1 $130.4M $157.9M $2.60 $2.15 $0.44
01/27/2025 Q4 $128.1M $164.6M $2.37 $2.24 $0.13
10/28/2024 Q3 $127.8M $170.3M $2.35 $2.29 $0.06
07/22/2024 Q2 $123.1M $157.7M $2.42 $2.00 $0.42
04/19/2024 Q1 $117.4M $152.8M $2.17 $1.83 $0.35
01/22/2024 Q4 $120.6M $140.7M $1.51 $1.91 -$0.40
10/23/2023 Q3 -- $148.6M $2.28 -- --
07/24/2023 Q2 -- $139.7M $1.94 -- --
04/21/2023 Q1 -- $135.3M $2.07 -- --
01/23/2023 Q4 -- $135.3M $2.02 -- --
10/24/2022 Q3 -- $134.7M $2.57 -- --
07/25/2022 Q2 -- $119.5M $2.10 -- --
04/22/2022 Q1 -- $112.8M $2.38 -- --
01/24/2022 Q4 -- $119.5M $2.23 -- --
10/25/2021 Q3 -- $117.8M $2.16 -- --
07/26/2021 Q2 -- $119.2M $2.38 -- --
05/06/2021 Q1 -- $117.4M $2.61 -- --
01/25/2021 Q4 -- $124.5M $2.75 -- --
10/26/2020 Q3 -- $124.9M $1.88 -- --
07/27/2020 Q2 -- $119.4M $1.80 -- --
04/27/2020 Q1 -- $112.4M $1.36 -- --
01/28/2020 Q4 -- $116.3M $1.45 -- --
10/28/2019 Q3 -- $119.4M $1.89 -- --
07/22/2019 Q2 -- $114.9M $1.33 -- --
04/19/2019 Q1 -- $103.8M $1.62 -- --
01/28/2019 Q4 -- $109.4M $1.67 -- --
10/22/2018 Q3 -- $104.7M $1.56 -- --
07/23/2018 Q2 -- $97.7M $1.83 -- --
05/02/2018 Q1 -- $97.3M $2.02 -- --
01/22/2018 Q4 -- $95.8M $1.48 -- --
10/23/2017 Q3 -- $95.3M $1.44 -- --
07/24/2017 Q2 -- $90M $1.24 -- --
04/21/2017 Q1 -- $86.3M $1.31 -- --
01/23/2017 Q4 -- $93.8M $1.30 -- --
10/24/2016 Q3 -- $89M $1.78 -- --
07/25/2016 Q2 -- $86M $1.30 -- --
04/22/2016 Q1 -- $86.8M $1.21 -- --
01/25/2016 Q4 -- $86.7M $1.36 -- --

Park National Corp. Earnings Questions

  • How Much did Park National Corp. Generate in Revenue Last Quarter?

    Park National Corp. reported $169.5M worth of top line sales in its most recent quarter.

  • Did Park National Corp. Beat Earnings Last Quarter?

    Park National Corp. announced earnings per share of $2.92 which represents a beat of analyst forecast a $2.74 per share.

  • Is Park National Corp. Profitable?

    Park National Corp. reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Park National Corp. EPS Next Year?

    Park National Corp.'s earnings are forecast to grow from $9.32 per share to $8.93 per share next year representing an increase of 20.09%.

  • When is Park National Corp.'s Earnings Date?

    Park National Corp.'s next earnings date is January 26, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 24

Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.

Buy
85
HUT alert for Dec 24

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
63
GPCR alert for Dec 24

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock